Back to mobile site

Barclays Downgrades Bristol-Myers Squibb Co. (BMY) to Underweight

July 29, 2024 5:36 AM EDT Send to a Friend
(Updated - July 29, 2024 6:11 AM EDT)

Barclays analyst Carter Gould downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login